Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Human immunodeficiency virus 1 | Protease | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma mansoni | intracisternal A-particle retropepsin (A02 family) | Get druggable targets OG5_131408 | All targets in OG5_131408 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Entamoeba histolytica | retroviral aspartyl protease domain-containing protein | Protease | 99 aa | 102 aa | 32.4 % |
Entamoeba histolytica | retroviral aspartyl protease domain-containing protein | Protease | 99 aa | 102 aa | 32.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | adenosine deaminase | 0.1115 | 0.4684 | 0.5 |
Trichomonas vaginalis | adenosine deaminase, putative | 0.1115 | 0.4684 | 0.5 |
Mycobacterium leprae | Probable adenosine deaminase Add (ADENOSINE AMINOHYDROLASE) | 0.1115 | 0.4684 | 0.5 |
Leishmania major | adenine aminohydrolase | 0.1115 | 0.4684 | 0.5 |
Mycobacterium tuberculosis | Probable adenosine deaminase Add (adenosine aminohydrolase) | 0.1115 | 0.4684 | 0.5 |
Trichomonas vaginalis | adenosine deaminase, putative | 0.1115 | 0.4684 | 0.5 |
Mycobacterium ulcerans | adenosine deaminase | 0.1115 | 0.4684 | 0.5 |
Echinococcus granulosus | adenosine deaminase | 0.1115 | 0.4684 | 0.5 |
Entamoeba histolytica | adenosine deaminase, putative | 0.1115 | 0.4684 | 0.5 |
Treponema pallidum | adenosine deaminase | 0.1115 | 0.4684 | 0.5 |
Entamoeba histolytica | adenosine deaminase, putative | 0.1115 | 0.4684 | 0.5 |
Onchocerca volvulus | Adenosine deaminase homolog | 0.1115 | 0.4684 | 0.5 |
Echinococcus multilocularis | adenosine deaminase | 0.1115 | 0.4684 | 0.5 |
Toxoplasma gondii | Adenosine/AMP deaminase domain-containing protein | 0.1115 | 0.4684 | 0.5 |
Brugia malayi | Adenosine/AMP deaminase family protein | 0.1115 | 0.4684 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1115 | 0.4684 | 1 |
Toxoplasma gondii | Adenosine/AMP deaminase domain-containing protein | 0.1115 | 0.4684 | 0.5 |
Plasmodium vivax | adenosine deaminase, putative | 0.1115 | 0.4684 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 63 nM | Antiviral activity against HIV1 3B | ChEMBL. | 17981045 |
EC50 (functional) | = 270 nM | Antiviral activity against HIV1 3B in presence of 50% human serum | ChEMBL. | 17981045 |
Ki (binding) | = 861 pM | Inhibition of HIV1 protease | ChEMBL. | 17981045 |
Ki (binding) | = 861 pM | Inhibition of HIV1 protease | ChEMBL. | 17981045 |
Stabilty (ADMET) | = 53 % | Metabolic stability in human liver microsomes assessed as compound remaining at 5 uM in presence of NADPH by RP-HPLC | ChEMBL. | 17981045 |
Stabilty (ADMET) | > 95 % | Metabolic stability in human liver microsomes assessed as compound remaining at 5 uM in presence of UDPGA by RP-HPLC | ChEMBL. | 17981045 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.